Back
Invesco Active US Real Estate ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
38
PSR
Invesco Active US Real Estate ETF
Last Price:
$91.02
Seasonality Move:
1.22%
Sell
34
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.71
Seasonality Move:
-18.07%
Sell
38
Invesco Active US Real Estate ETF (PSR)
is a Sell
Is Invesco Active US Real Estate ETF a Buy, Sell or Hold?
-
The current Invesco Active US Real Estate ETF [PSR] share price is $91.04. The Score for PSR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
PSR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSR Stock Price Chart
What is Invesco Active US Real Estate ETF's stock price today?
-
The Invesco Active US Real Estate ETF share price today is $91.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSR is experiencing selling pressure, which indicates risk of future bearish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
PSR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.26 | Buy |
| Relative Strength Index (14 RSI): | 47.13 | Sell |
| Chaikin Money Flow: | -784 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.69 - 92.01) | Sell |
| Bollinger Bands (100): | (90.73 - 92.83) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | -20975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.65) | Sell |
| Bollinger Bands (100): | (12.3 - 15.28) | Sell |
PSR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.95 | Buy |
| 20-day SMA: | 91.33 | Sell |
| 50-day SMA: | 91.72 | Sell |
| 200-day SMA: | 91.57 | Sell |
| 8-day EMA: | 20.23 | Buy |
| 20-day EMA: | 8.67 | Buy |
| 50-day EMA: | 3.57 | Buy |
| 200-day EMA: | 0.91 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.32 | Sell |
| 20-day SMA: | 11.56 | Buy |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 11.86 | Sell |
| 8-day EMA: | 12.05 | Sell |
| 20-day EMA: | 12.05 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12.23 | Sell |
Invesco Active US Real Estate ETF Earnings Growth & PSR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Invesco Active US Real Estate ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||